Loading…
Aggressive Mesenchymal chondrosarcoma of the maxilla: Case report
Chondrosarcomas of the head and neck are extremely rare, accounting for approximatively 0.1% of all head and neck malignant tumors. Mesenchymal chondrosarcomas are particularly aggressive, with a high propensity for recurrence. We report the case of a 25 years old man with no prior medical history,...
Saved in:
Published in: | International journal of surgery case reports 2022-02, Vol.91, p.106696-106696, Article 106696 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Chondrosarcomas of the head and neck are extremely rare, accounting for approximatively 0.1% of all head and neck malignant tumors. Mesenchymal chondrosarcomas are particularly aggressive, with a high propensity for recurrence.
We report the case of a 25 years old man with no prior medical history, who presented to our facility with an aggressive tumor of the left maxilla. Upon radiologic and histopathological examinations, the tumor was revealed to be a mesenchymal chondrosarcoma. The patient was treated using surgical excision of the tumor, neoadjuvant chemotherapy and adjuvant radiotherapy.
Due to the high risk of recurrence and the possibility of metastasis occurring long after the initial diagnosis, it is important that patients with mesenchymal chondrosarcomas receive close and regular follow-ups after treatment.
•Maxillary chondrosarcoma generally presents as a painless tissue mass in the nasal cavities.•In our case, the patient presented with many symptoms on his first consultation due to the advanced stage of tumor extension which has invaded the ipsilateral nasal cavity, the nasopharynx, oropharynx the hard palate and which arrives at the orbit without invading it.•This case underlines the interest of multidisciplinary consultation because thanks to the decision of a first chemotherapy, the patient could then benefit from a carcinological surgery.•The interest of a regular long-term follow-up given the high risk of recurrence. |
---|---|
ISSN: | 2210-2612 2210-2612 |
DOI: | 10.1016/j.ijscr.2021.106696 |